Cite
Refractory pityriasis rubra pilaris treated with etanercept, adalimumab, or ustekinumab: A retrospective investigation.
MLA
Maloney, Nolan J., et al. “Refractory Pityriasis Rubra Pilaris Treated with Etanercept, Adalimumab, or Ustekinumab: A Retrospective Investigation.” Dermatologic Therapy, vol. 30, no. 6, Nov. 2017, p. n/a-N.PAG. EBSCOhost, https://doi.org/10.1111/dth.12559.
APA
Maloney, N. J., Hisaw, L. D., & Worswick, S. (2017). Refractory pityriasis rubra pilaris treated with etanercept, adalimumab, or ustekinumab: A retrospective investigation. Dermatologic Therapy, 30(6), n/a-N.PAG. https://doi.org/10.1111/dth.12559
Chicago
Maloney, Nolan J., Lisa D. Hisaw, and Scott Worswick. 2017. “Refractory Pityriasis Rubra Pilaris Treated with Etanercept, Adalimumab, or Ustekinumab: A Retrospective Investigation.” Dermatologic Therapy 30 (6): n/a-N.PAG. doi:10.1111/dth.12559.